StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for GBCS yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-14 | $3.45 | $3.45 | +0.00% | 0.0M |
| 05-18 | $3.55 | $3.61 | +1.63% | 0.0M |
| 05-19 | $3.55 | $3.55 | +0.00% | 0.0M |
| 05-20 | $3.31 | $3.31 | +0.00% | 0.0M |
| 05-22 | $3.40 | $2.97 | -12.65% | 0.0M |
SELECTIS HEALTH INC
Fundamentals not available for GBCS yet.
We pull from FMP, Finnhub, and Polygon — common gaps are very recent IPOs that haven't filed their first 10-Q, pink-sheet OTC tickers, and foreign filers without US-listed depth. The Financials tab reads SEC EDGAR directly and may still have data here.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.29M | $41.44M | $31.77M | $20.93M |
Operating Income | $-1.26M | $-1.56M | $-1.17M | $-872.03K |
Net Income | $6.53M | $-1.02M | $-211.63K | $-964.00K |
EPS (Diluted) | $1.90 | $-0.34 | $-0.08 | $-0.32 |
Total Assets | $30.01M | $32.58M | $33.26M | $33.64M |
Total Liabilities | $29.75M | $38.79M | $38.92M | $40.03M |
Cash & Equivalents | $1.29M | $1.01M | $417.13K | $559.98K |
Free Cash Flow OCF − CapEx | $-2.67M | $1.44M | $851.07K | $575.28K |
Shares Outstanding | 3.07M | 3.07M | 3.07M | 3.07M |